3650 results for «248»

Filter By

3650 results

PCR Tokyo Valves 2026 Closing Ceremony

15 Feb 2026 – From PCR Tokyo Valves 2026

The Closing Ceremony marks the conclusion of this cardiology conference, providing a formal wrap-up and reflection on the key highlights and advancements presented throughout the event. It serves as an opportunity to acknowledge contributors and set the stage for future initiatives in interventional cardiology.

PCR Tokyo Valves 2026 Closing Ceremony

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

13 Feb 2026 – From PCR Tokyo Valves 2026

Delve into the assessment of mitral regurgitation and the criteria determining suitability for Transcatheter Edge-to-Edge Repair (TEER). This session reviews mitral valve anatomy and the latest clinical data supporting mitral TEER interventions.

Mastering techniques from basic to complex - Mitral regurgitation assessment and suitability for TEER

Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging

13 Feb 2026 – From PCR Tokyo Valves 2026

Advance your expertise in mitral TEER by gaining anatomical insights, understanding device interaction with native valve structures, and learning to prevent and manage procedural complications through case-based imaging and live assessments.

Mastering techniques from basic to complex - Tips and tricks for advanced mitral TEER: anatomy and imaging

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

13 Feb 2026 – From PCR Tokyo Valves 2026

Gain foundational knowledge in tricuspid TEER by understanding anatomical criteria for patient suitability, key procedural steps, and device techniques, enhanced by simulation-based procedural training.

Mastering techniques from basic to complex - Tricuspid TEER fundamentals

Getting ready for tricuspid TEER: key steps in building a successful programme

14 Feb 2026 – From PCR Tokyo Valves 2026

Prepare to establish a successful tricuspid TEER programme by understanding essential components such as systematic echocardiographic and clinical assessments for patient selection, procedural fundamentals, and programme development supported by clinical evidence.

Getting ready for tricuspid TEER: key steps in building a successful programme

DK Crush like you’ve never seen it before

  • Multi-modality simulation to unveil the hidden parts & small obstacles that can result in complications
  • Angioscopy directly inside the coronary artery to provide a better understanding of 3D stent configuration

Commented by Goran Stankovic and William Wijns

Part 1 of a 3-part series.
Next episode: How to correct incomplete crush and...

DK Crush like you’ve never seen it before

How to correct incomplete crush and how to prevent lack of carina coverage

  • Differentiating between complete and incomplete crush
  • The importance of sequential crush and bigger balloons, adequately sized according to proximal vessel diameter

Commented by Goran Stankovic and William Wijns

Part 2 of a 3-part series:  
Previous episode: DK Crush like you’ve never seen it before
Coming up next: Main vessel stenting in DK-Crush, lessons...

How to correct incomplete crush and how to prevent lack of carina coverage

Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy

  • Optimisation of side branch stenting
  • How to optimally deploy the second stent

Commented by Goran Stankovic and William Wijns

Part 3 of a 3-part series. Previous episode: How to correct incomplete crush and how to prevent lack of carina coverage

Main vessel stenting in DK-Crush: lessons from stepwise provisional strategy

RESHAPE-HF2 - Percutaneous repair of moderate-to-severe or severe functional mitral regurgitation in patients with symptomatic heart failure

01 Sep 2024

Nicola Ryan provides her take on the RESHAPE-HF2 trial presented by Stefan Anker at the ESC Congress 2024 in London and simultaneously published in the NEJM.

The RESHAPE-HF 2 trial is a prospective randomised control trial comparing transcatheter mitral valve repair (TEER) and guideline-directed medical therapy to guideline-directed medical...

Nicola Ryan

Author

Nicola Ryan
RESHAPE-HF2

Insights from the Corevalve US Pivotal and SURTAVI trials

05 Apr 2022

Pierre Deharo and Giuseppe Di Gioia provide their take on this analysis of the 5 years incidence, outcomes and predictors of hemodynamic SVD in patients undergoing TAVI and surgery from the Corevalve US Pivotal and SURTAVI trials.

Pierre Deharo

Author

Pierre Deharo
Giuseppe Di Gioia

Author

Giuseppe Di Gioia
Insights From the Corevalve US Pivotal and SURTAVI Trials
Didn’t find what you were looking for?